Avantax Advisory Services, Inc. Adamis Pharmaceuticals Corp Transaction History

Avantax Advisory Services, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$0.55 - $0.73 $17,600 - $23,360	-32,000 Reduced 59.26%	22,000 $13,000
Q4 2021 Jan 24, 2022	BUY	$0.57 - $1.23 $12,539 - $27,060	22,000 Added 68.75%	54,000 $33,000
Q2 2021 Jul 29, 2021	BUY	$0.66 - $1.23 $21,120 - $39,360	32,000 New	32,000 $35,000
Q3 2020 Oct 14, 2020	SELL	$0.52 - $1.45 $8,840 - $24,650	-17,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.51 - $1.26 $3,570 - $8,820	7,000 Added 70.0%	17,000 $12,000
Q3 2019 Nov 08, 2019	BUY	$0.7 - $1.46 $7,000 - $14,600	10,000 New	10,000 $7,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Avantax Advisory Services, Inc. with notifications on news.